Intrinsiqs

Is Enovis Corporation overvalued?

Enovis Corporation (ENOV) looks undervalued — trading about 140% below its fair value.

Undervalued
Current price $26.06 Fair value $62.46
Price
$26.06
Fair value
$62.46
Current P/E
7.7
Normal P/E
18.5
Market cap
$1.50B
Dividend yield
0.0%
Return on equity
-68.2%
Sector
Healthcare

See the full interactive analysis →

Fair value compares ENOV's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.